XML 96 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tax Contingencies) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Tax Contingency [Line Items]        
Unrecognized Tax Benefits Net Liabilities $ 44 $ 112    
Unrecognized tax benefits (45) [1] (144) [1] (114) [1] (93)
Unrecognized Tax Benefits, Adjustments Associated With The Separation 115 [2] 0 [2] 0 [2]  
Unrecognized Tax Benefits, Increase Resulting from Acquisition 0 [3] 0 [3] (19) [3]  
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions (2) [4] (2) [4] 0 [4]  
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 0 [4],[5] 40 [4],[5] 1 [4],[5]  
Unrecognized Tax Benefits Decreases Resulting From Prior Period Cash Period 1 3 7  
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions (16) [4] (73) [4] (10) [4]  
Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 0 0 0  
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 1 2 0  
Unrecognized tax benefits, exclusive of interest related to unrecognized tax benefits 3 1    
Unrecognized Tax Benefits, Interest on Income Taxes Accrued 11 17    
Other Noncurrent Assets
       
Income Tax Contingency [Line Items]        
Unrecognized Tax Benefits Assets 1 32    
Noncurrent Deferred Tax Assets
       
Income Tax Contingency [Line Items]        
Unrecognized tax benefits (6) (6)    
Other Taxes Payable
       
Income Tax Contingency [Line Items]        
Unrecognized tax benefits $ (39) $ (138)    
[1] In 2013, included in Noncurrent deferred tax assets ($6 million) and Other taxes payable ($39 million). In 2012, included in Noncurrent deferred tax assets ($6 million) and Other taxes payable ($138 million).
[2] The significant decrease in the total gross unrecognized tax benefits from December 31, 2012 to December 31, 2013 is primarily attributable to the elimination of net tax liabilities associated with uncertain tax positions that were retained by Pfizer. See Note 2B. The Separation, Adjustments Associated with the Separation, Senior Notes Offering, Initial Public Offering and Exchange Offer— Adjustments Associated with the Separation.
[3] The amount in 2011 primarily relates to the acquisition of KAH.
[4] Primarily included in Provision for taxes on income.
[5] In all years, the decreases are primarily a result of effectively settling certain issues with the U.S. and non-U.S. tax authorities. See A. Tax Matters—Taxes on Income.